Top 5 Hudson Structured Capital Management Ltd. Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| KAIR | KAIROS ACQUISITION CORP | 71.24% | 1.98M | $19.9M | — | — | — | 2022-12-31 |
| LMND | LEMONADE INC | 18.75% | 383.4K | $5.2M | — | — | — | 2022-12-31 |
| CLOV | CLOVER HEALTH INVESTMENTS CO | 6.56% | 1.97M | $1.8M | — | — | — | 2022-12-31 |
| DOMA | DOMA HOLDINGS INC | 3.45% | 2.13M | $964K | — | — | — | 2022-12-31 |
| KAIRW | KAIROS ACQUISITION CORP | 0% | 6.28M | $628 | — | — | — | 2022-12-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — |
| Top 20 Holdings Unweighted | — | — | — | — |
Hudson Structured Capital Management Ltd. reports $27.97K in US-listed equity holdings across 5 positions in its most recent 13F filing. Its largest disclosed positions are KAIR (71.2%), LMND (18.8%) and CLOV (6.6%). Figures reflect the Q4 2022 filing.
Sign up free to track Hudson Structured Capital Management Ltd., compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Hudson Structured Capital Management Ltd.’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1841183). View Hudson Structured Capital Management Ltd.’s 13F filings on SEC